Kurome Therapeutics rakes in $15m Series A

Kurome Therapeutics, a preclinical stage company, has secured $15 million in Series A financing.

Kurome Therapeutics, a preclinical stage company, has secured $15 million in Series A financing. Medicxi and Affinity Asset Advisors led the round.

Source: Press Release